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Background: The purpose of the optic nerve sheath diameter (ONSD) research group project is to establish an
individual patient-level database from high quality studies of ONSD ultrasonography for the detection of raised
intracranial pressure (ICP), and to perform a systematic review and an individual patient data meta-analysis (IPDMA),
which will provide a cutoff value to help physicians making decisions and encourage further research. Previous
meta-analyses were able to assess the diagnostic accuracy of ONSD ultrasonography in detecting raised ICP but
failed to determine a precise cutoff value. Thus, the ONSD research group was founded to synthesize data from
several recent studies on the subject and to provide evidence on the diagnostic accuracy of ONSD ultrasonography
in detecting raised ICP.
Methods: This IPDMA will be conducted in different phases. First, we will systematically search for eligible studies.
To be eligible, studies must have compared ONSD ultrasonography to invasive intracranial devices, the current
reference standard for diagnosing raised ICP. Subsequently, we will assess the quality of studies included based on
the QUADAS-2 tool, and then collect and validate individual patient data. The objectives of the primary analyses
will be to assess the diagnostic accuracy of ONSD ultrasonography and to determine a precise cutoff value for
detecting raised ICP. Secondly, we will construct a logistic regression model to assess whether patient and study
characteristics influence diagnostic accuracy.
Discussion: We believe that this IPD MA will provide the most reliable basis for the assessment of diagnostic
accuracy of ONSD ultrasonography for detecting raised ICP and to provide a cutoff value. We also hope that the
creation of the ONSD research group will encourage further study.
Trial registration: PROSPERO registration number: CRD42012003072
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Introduction
Raised intracranial pressure (ICP) is a common life-
threatening condition that can occur in multiple neuro-
logical or non-neurological settings. The ‘gold standard’
for diagnosing raised ICP is the use of intracranial de-
vices [1,2]. However, this requires an invasive method
that has multiple disadvantages, namely severe compli-
cations (infection, hemorrhage, malfunction) [3-5] and
non-feasibility due to absence of available neurosurgical
expertise or contraindications (coagulopathy, thrombo-
cythemia) [6].
Several non-invasive methods have been developed in
order to propose an alternative, such as neuroimaging
and transcranial Doppler sonography. However, the ac-
curacy of these methods in predicting ICP values ap-
pears to be limited [7-10].
Optic nerve sheath ultrasonography provides a very
promising bedside tool for the detection of raised ICP.
Since the optic nerve is a part of the central nervous
system, it is surrounded by cerebrospinal fluid (CSF).
Thus, if CSF circulation is not blocked, an increase in
ICP will be transmitted through the subarachnoid space
surrounding the optic nerve, within the nerve sheath, es-
pecially the retrobulbar segment [11].
Rationale for an individual patient data meta-analysis
Individual patient data meta-analysis (IPDMA) is consid-
ered to be the least biased method and ‘gold standard’
for addressing questions that cannot be resolved by a
single study [12,13]. Several individual studies have dem-
onstrated that optic nerve sheath diameter (ONSD)
ultrasonography provides good diagnostic accuracy in
the detection of raised ICP. However these studies have
limited statistical power to provide a definitive cutoff
value of ONSD to predict ICP above 20 mmHg (the
usual threshold for raised ICP) due to small sample size.
The two current published meta-analyses [14,15] of ag-
gregated data from published studies identified six such
studies with relevant data providing evidence on the
diagnostic accuracy of ONSD ultrasonography, but they
did not allow any clear conclusions on a pinpoint cutoff
value. Indeed authors of each individual study have tried
to determine the ONSD threshold in millimeters above
which ICP is superior or equal to 20 mmHg, defining
raised ICP by constructing a receiver operator character-
istic (ROC) curve. This threshold varies from 4.8 mm to
5.9 mm according to studies [14-16]. An IPDMA is
required to define an accurate cutoff. The other main
advantage of IPDMA compared to meta-analysis of ag-
gregated data is the potential to undertake data checking
and ensure appropriateness of analysis. The statistical
power is increased owing to the incorporation of indi-
vidual patient covariates and differences between studies.The interaction of these covariates accounts for a greater
proportion of explained data than analysis of mean
values for patient characteristics and study differences
performing with aggregated data.
Objectives
The overarching objective is:
1) To establish an individual patient-level database
from high quality studies of ONSD ultrasonography
in the detection of raised ICP. We will assess the
diagnostic accuracy of this non-invasive tool and
address several key points.
The primary analytic objectives are:
2) To determine the diagnostic accuracy of ONSD
ultrasonography in the detection of raised ICP
(> 20 mmHg). The diagnostic accuracy will be
expressed as sensitivity, specificity, and positive and
negative likelihood values, including a diagnostic
odds ratio.
3) To define the cutoff value for ONSD
ultrasonography in the detection of raised
intracranial ICP (> 20 mmHg). This value will be
obtained from patient-level data.
For objectives 2) and 3), analyses will be performed ex-
clusively using studies that compare ultrasonography
with the ‘gold standard’ measure of ICP, invasive intra-
cranial devices.
The secondary objectives are:
4) To determine whether the diagnostic accuracy of
ONSD ultrasonography varies according to patient
characteristics (for example age, weight, initial
diagnosis, medical treatment).
5) To determine whether the diagnostic accuracy of
ONSD ultrasonography varies according to study
characteristics (for example experience of
sonographer, trademark of devices).
Furthermore, this IPD MA will allow analysis of
subgroups. We do not expect to find any difference
in diagnostic accuracy between patient characteristics.
However, it is mandatory to explore all possibilities of
variation in order to make strong conclusions.
Methods
This study is exempt from an institutional review board
and/or ethical oversight because it involves analysis of
de-identified data that has already been collected for a
separate purpose. Therefore, it will not be possible to
trace data back to individual patients.
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Two authors (JD, MM) will search Medline using
PubMed interface, Embase, Pascal Biomed, Google
Scholar and the Cochrane database from inception to
January 2013. We will use the same search strategy as
for our previous review [14]. Both authors will also
review reference lists of identified studies manually and
scanned abstracts from recent conference proceedings
(from 2005 to 2011). Finally, ongoing trials will be
searched using ClinicalTrials.gov. No language restric-
tion will be applied.
In order to remove any clearly inappropriate titles,
both authors will scan all retrieved references. Hard cop-
ies of all remaining papers will then be obtained and
read by both authors to remove any for which there is
no possibility of eligibility. Studies will be eligible if they
actually assessed the diagnostic accuracy of ONSD ultra-
sonography with intraparenchymal or intraventricular
devices for ICP monitoring. Studies will be excluded if
invasive intracranial devices were not of the ‘gold stand-
ard’. Differences regarding eligibility will be resolved by
consensus and with the help of the senior author (TG).
Quality assessment
We will use the QUADAS-2 tool [17] to assess the qual-
ity of the studies. Two authors (JD and MM) will inde-
pendently assess the quality of each study. High quality
and low quality studies will be distinguished and
grouped. Four primary criteria will be used as in our
previous systematic review [14]: 1) the presence of an
independent blind comparison with the ‘gold standard’;
2) inclusion in the population studied of an appropriate
spectrum of patients on whom the test would be applied
in clinical practice; 3) an adequate description of ultra-
sonography of ONSD to allow reproducibility of the
method; and 4) a short delay (< 1 hour) between the two
tests. High quality studies will have to fulfill all four cri-
teria. Studies that do not fulfill these criteria will be
qualified as lower quality. If we find important differ-
ences with regards to study quality, subgroup analyses
will be performed for each different overall quality.
Data collection
We will approach all authors whose studies meet the
inclusion criteria to inform them about the IPDMA pro-
ject and invite them to share their data in this collabora-
tive study. If they are inclined to participate, we will
request from them the following data for individual
patients: age; sex; height; weight; baseline systolic arterial
pressure; baseline diastolic arterial pressure; diagnoses;
Marshall score, if applicable; Glasgow Coma Scale
(GCS); type (hyperosmolar therapy, invasive ventilation,
sedation, neurosurgery) and dose of treatment before ICP
and ONSD measurements; delay between computerizedtomography (CT)scan and ONSD ultrasonography; exist-
ence of any episode of raised ICP before ONSD ultrason-
ography; type of ICP devices (intraparenchymal or
intraventricular) used; trademark of ICP devices; name
and degree of clinical experience of the sonographer;
trademark of sonography; frequency of the sonography
probe; number of ONSD measurements and for each
measurement, the existence of blinded measures; delay
between the two measures; ONSD measures (transverse
and sagittal planes for both eyes); ICP value; and delay
since previous ONSD measurements.
Raised ICP will be defined a priori by invasive meas-
urement > 20 mmHg in adults (age > 18 years old).
We will also ask authors to examine the provisional
study list to identify any additional studies that they may
be aware of, in order to include any study that may have
been missed by our search criteria or that has not been
published.
Individual patient data will be sought for all included
studies and entered into a single database. Study level
data will then be added to individual patient records.
This raw dataset will be saved in its original format,
then converted to a Stata format (StataCorp, College
Station, TX, USA), since Stata will be the statistical soft-
ware used for analysis, and then saved again. Statistical
coding will be written for the initial setup. Each variable
will then be renamed to a standard notation and given a
standard label. Any variable that cannot be identified or
is ambiguous will be documented and appropriate clari-
fication sought from the original investigator.
Data validation
We will keep original data on a secure server with a
backup copy according to a pre-specified data security
agreement policy. Two authors (JD and MM) will
crosscheck data from studies against data found in pub-
lished articles. Any inconsistency will be discussed with
the original author and corrections will be made when ne-
cessary. Requirements for authorship will be according to
the International Committee of Medical Journal Editors,
and a representative of each study will be invited to be
part of the steering committee before publication to dis-
cuss analysis and results.
Statistical analysis
The data synthesis will be performed using methods
recommended by the working group of the Cochrane
Collaboration on systematic reviews of diagnostic test
accuracy.
For each study, we will construct 2 × 2 tables compar-
ing the dichotomized test result with the final ICP status.
We will then calculate sensitivity and specificity, and
plot the results in a ROC space. We will perform a ROC
analysis and an area under the curve (AUC) on ONSD
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estimated and weighted for the sample size of each study.
Additionally, individual patient’s data from all studies
will be pooled and directly analysed for diagnostic accur-
acy. Several analyses will be performed: 1) building of
the empirical ROC curve and estimation of the area
under the ROC curve, irrespective of the original study;
2) building of ROC curves based on a logistic regression
model with mixed effects, in which the model will allow
the odds ratio of the diagnostic test to vary according
to the study; 3) modeling of the ROC curve according
to the characteristics of the patients and studies. The
approach developed by Alonzo et al. [18] will be
implemented using Stata software. This analysis will
allow quantification of the adjusted effect of the dif-
ferent characteristics on the diagnostic accuracy of
ONSD; and 4) point estimation and interval estima-
tion of the optimal threshold of ONSD, taking into
account the prevalence of raised ICP in the studied
population and the preference to avoid false negative
or false positive results. The method developed by
Subtil et al. [19] will be used to estimate the thresh-
old with its credibility interval.
To perform sensitivity analysis, the analysis will be
redone by leaving out one study. For the same purpose,
we will also exclude low quality studies (defined above)
and the analysis will be redone. Other sensitivity ana-
lyses will be undertaken in case of subsequently identi-
fied factors that would influence conclusions.
Discussion
Our study will use individual patient data for the assess-
ment of diagnostic accuracy of ONSD ultrasonography
in the detection of raised ICP and to determine a precise
cutoff value. We believe that the findings of the ONSD
research group will have an important implication for
both clinical practice and research. This IPDMA will
provide the most reliable cutoff value of ONSD ultra-
sonography in the detection of raised ICP. This cutoff
will no doubt be the starting point for new studies on
this promising tool. Indeed, this cutoff will enable physi-
cians to commence a large-scale trial to validate and test
the tool in their own settings. Above all, we hope that
the creation of the ONSD research group may serve as a
model for future studies or research in this field. In this
group, physicians, statisticians and other researchers
have elected to share raw data and develop a robust
partnership to improve clinical findings.
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